OFI Invest Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.8M Sell
529,615
-9,192
-2% -$499K 0.2% 106
2026
Q1
$29.4M Buy
538,807
+204,565
+61% +$16.4M 0.39% 67
2025
Q4
$27.2M Buy
334,242
+323,637
+3,052% +$31.7M 0.39% 67
2025
Q3
$881K Sell
10,605
-2,212
-17% -$229K 0.02% 164
2025
Q2
$1.17M Buy
12,817
+3,317
+35% +$336K 0.03% 150
2025
Q1
$887K Buy
+9,500
New +$957K 0.02% 194
2024
Q2
$35.9K Buy
+499
New +$36.5K ﹤0.01% 290
2023
Q2
Sell
-162,247
Closed -$3.24M 110
2023
Q1
$3.24M Buy
+162,247
New +$7.65M 0.02% 103

Other funds holding BSX

OFI Invest Asset Management's BSX Position: Q2 2026 in Review

OFI Invest Asset Management reduced its Boston Scientific (BSX) stake by 1.7% in Q2 2026, selling an estimated $499K and leaving 529,615 shares worth $19.8M. The position accounts for 0.2% of the portfolio, ranked #106.

OFI Invest Asset Management first reported a position in BSX in Q1 2023 and has held it in 8 quarters since. The position peaked at $29.4M in Q1 2026. 828 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • OFI Invest Asset Management held 529,615 shares of Boston Scientific worth $19.8M as of Q2 2026.
  • OFI Invest Asset Management sold 9,192 Boston Scientific shares in Q2 2026, an estimated $499K.
  • Boston Scientific made up 0.2% of OFI Invest Asset Management's portfolio in Q2 2026, its #106 holding.
  • OFI Invest Asset Management first reported a position in Boston Scientific in Q1 2023 and has held it in 8 quarters since.
  • OFI Invest Asset Management's Boston Scientific position peaked at $29.4M in Q1 2026.
  • 828 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.